Bristol-Myers Squibb Company - About Prescription Drugs

WASHINGTON (Reuters) - A Senate panel voted on Thursday to bar drug companies from paying generic drugmakers to delay bringing their cheaper medicines to market. The Judiciary Committee voted 12 to 7 to forbid such deals. Lawmakers are seeking to ban the ...